Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02510 |
| Species: | Mus musculus |
| Position : | chr8:92145800-92146600 |
| Year: | 2016 |
| Title: | Foxd3 Promotes Exit from Naive Pluripotency through Enhancer Decommissioning and Inhibits Germline Specification |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 26748758 |
| MONDO: | |
| Tissue: | Embryo |
| Tissue Ontology ID: | UBERON:0000922 |
| Cell Source: | mESC |
| CVCL ID: | |
| Cell Type: | mouse embryonic stem cell |
| Cell Ontology ID: | CL:0002322 |
| Experiment Type: | TF binding assay |
| High Throughput Method: | ChIP-seq |
| Low Throughput Method: | ChIP-RT-qPCR |
| Target gene : | Foxd3 |
| TF name : | Foxd3 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Foxd3 | POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | reactome | 13 |
| Foxd3 | Hs_Neural_Crest_Differentiation_WP2064_79263 | wikipathways | 40 |